Targeting AKT/PKB to improve treatment outcomes for solid tumors von Iida, M., Harari, P. M., Wheeler, D. L., Toulany, M.

Volltext

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members von Wheeler, D L, Huang, S, Kruser, T J, Nechrebecki, M M, Armstrong, E A, Benavente, S, Gondi, V, Hsu, K-T, Harari, P M

Volltext

Epidermal growth factor receptor inhibition strategies in oncology von Harari, P M

Volltext

SP-0603: Interaction of radiotherapy with molecular targeting agents von Harari, P

Volltext

Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck von Argiris, A., Kotsakis, A.P., Hoang, T., Worden, F.P., Savvides, P., Gibson, M.K., Gyanchandani, R., Blumenschein, G.R., Chen, H.X., Grandis, J.R., Harari, P.M., Kies, M.S., Kim, S.

Volltext

SP-052: Against the Motion von Harari, P

Volltext

Modulation of Radiation Response after Epidermal Growth Factor Receptor Blockade in Squamous Cell Carcinomas: Inhibition of Damage Repair, Cell Cycle Kinetics, and Tumor Angiogenes... von HUANG, S.-M, HARARI, P. M

Volltext

Fragmentomic analysis of circulating tumor DNA-targeted cancer panels von Helzer, K.T., Sharifi, M.N., Sperger, J.M., Shi, Y., Annala, M., Bootsma, M.L., Reese, S.R., Taylor, A., Kaufmann, K.R., Krause, H.K., Schehr, J.L., Sethakorn, N., Kosoff, D., Kyriakopoulos, C., Burkard, M.E., Rydzewski, N.R., Yu, M., Harari, P.M., Bassetti, M., Blitzer, G., Floberg, J., Sjöström, M., Quigley, D.A., Dehm, S.M., Armstrong, A.J., Beltran, H., McKay, R.R., Feng, F.Y., O’Regan, R., Wisinski, K.B., Emamekhoo, H., Wyatt, A.W., Lang, J.M., Zhao, S.G.

Volltext

Effect of Injection Timing and Injection Duration of Manifold Injected Fuels in Reactivity Controlled Compression Ignition Engine Operated with Renewable Fuels von Harari, P. A., Banapurmath, N. R., Yaliwal, V. S., Khan, T. M. Yunus, Badruddin, Irfan Anjum, Kamangar, Sarfaraz, Mahlia, Teuku Meurah Indra

Volltext

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck von HUANG, S.-M, BOCK, J. M, HARARI, P. M

Volltext

Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database von Brower, J.V., Amini, A., Chen, S., Hullett, C.R., Kimple, R.J., Wojcieszynski, A.P., Bassetti, M., Witek, M.E., Yu, M., Harari, P.M., Baschnagel, A.M.

Volltext

Promising new advances in head and neck radiotherapy von HARARI, P. M

Volltext

Radiation Combined With EGFR Signal Inhibitors: Head and Neck Cancer Focus von Harari, Paul M., Huang, Shyhmin

Volltext

(P071) Management and Survival Outcomes for Lymph Node Negative T3 Squamous Cell Carcinoma of the Glottic Larynx von Ko, H, Chen, S, Yu, M, Wieland, A, Hartig, G, Harari, P, Witek, M

Volltext

Intensity-modulated radiation therapy: emerging cancer treatment technology von HONG, T. S, RITTER, M. A, TOME, W. A, HARARI, P. M

Volltext

Potential Influence of ACE Inhibitors and Angiotensin Receptor Blockers on Outcome in Patients With Oropharynx Cancer Treated With Radiation Therapy von Magnuson, W.J, Morris, Z, Mohindra, P, Geye, H, Harari, P

Volltext

OC-006: Outcomes of head and neck cancer with N3 nodal disease: a review of the National Cancer Data Base von Ko, H.C, Chen, S, Wieland, A, Yu, M, Baschnagel, A, Brower, J, McCulloch, T, Hartig, G, Harari, P, Witek, M

Volltext

Rates of Malignancy in Incidental and Asymptomatic Parotid Lesions von Britt, C.J, Patel, P, Stein, A, Harari, P, Hartig, G

Volltext

Radiation and New Molecular Agents, Part II: Targeting HDAC, HSP90, IGF-1R, PI3K, and Ras von Chinnaiyan, Prakash, Allen, Gregory W., Harari, Paul M.

Volltext

Impact of Node Negative (N0) Target Volume on Parotid Gland Dose Sparing in HNSCC von Magnuson, W.J, Urban, E, Bayliss, A, Harari, P

Volltext